Induction of reactive oxygen species in neurons haloperidol

Journal of Neurochemistry

Volumn 71, Issue 3, 1998, Pages 1002-1012

  Sagara, Yutaka ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Antioxidants; Antipsychotic drug; Ca2+ influx; Cell death; Glutathione; Haloperidol; Mitochondrial membrane potential; Necrosis; Neuroleptic; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ESTRADIOL; GLUTATHIONE; HALOPERIDOL; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG INDUCED DISEASE; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0031844208     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71031002.x     Document Type: Article

References (80)

1. 2+-dependent late phase. J. Neurochem. 67, 2074-2078.
2. Anderson M. E. and Meister A. (1989) Glutathione monoesters. Anal. Biochem. 183, 16-20.
3. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., and Nicotera P. (1995) Glutamate-induced neuronal cell death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
4. Baldessarini R. J., Cohen B. U., and Teicher M. H. (1988) Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis. Arch. Gen. Psychiatry 45, 179-191.
5. Banki K., Hutter E., Colombo E., Gonchoroff N. J., and Perl A. (1996) Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 271, 32994-33001.
6. Bass D. A., Parce J. W., Dechatelet L. R., Szejda P., Seeds M. C., and Thomas M. (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130, 1910-1917.
7. Behl C., Davis J., Cole G. M., and Schubert D. (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
8. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
9. Behl C., Rupprecht R., Skutella T., and Holsboer F. (1995a) Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro. Neuroreport 7, 360-364.
10. Behl C., Widman M., Trapp T., and Holsboer F. (1995b) 17-Beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-182.
11. Behl C., Lezoualc'h F., Widmann M., Rupprecht R., and Holsboer F. (1996) Oxidative stress-resistant cells are protected against haloperidol toxicity. Brain Res. 717, 193-195.
12. Boveris A., Oshino N., and Chance B. (1972) The cellular production of hydrogen peroxide. Biochem. J. 128, 617-630.
13. Bowen W. D., Moses E. L., Tolentino P. J., and Walker J. M. (1990) Metabolites of haloperidol display preferential activity at a receptors compared to dopamine D-2 receptors. Eur. J. Pharmacol. 177, 111-116.
14. Cadet J. L., Lohr J. B., and Jeste D. V. (1986) Free radical and tardive dyskinesia. Trends Neurosci. 9, 107-108.
15. Choi D.W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
16. Cino M. and Del Maestro R. F. (1989) Generation of hydrogen peroxide by brain mitochondria: the effect of reoxygenation following postdecapitative ischemia. Arch. Biochem. Biophys. 269, 623-638.
17. Cossarizza A., Ceccarelli D., and Masini A. (1996) Functional heterogeneity of an isolated mitochondria population revealed by cytofluorometric analysis at the single organelle level. Exp. Cell Res. 222, 84-94.
18. Davis J. B. and Maher P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169-173.
19. Dawson T. L., Gores G. J., Nieminen A.-L., Herman B., and Lemasters J. L. (1993) Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am. J. Physiol. 264, C961-C967.
20. Deas O., Dumont C. Mollereau B., Metivier D., Pasquier C., Bernard-Pomier G., Hirsch F., Charpentier B., and Senik A. (1997) Thiol-mediated inhibition of FAS and CD2 apoptotic signalling in activated human peripheral T cells. Int. Immunol. 9, 117-125.
21. Dobbelsteen D. J., Nobel C. S. I., Schlegel J., Cotgreave I. A., Orrenius S., and Slater A. F. (1996) Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chem. 271, 15420-15427.
22. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. M., Lin T. S., Goldberg M. P., and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
23. Elkashef A. M., Ruskin P. E., Bachen N., and Barret D. (1990) Vitamin E in the treatment of tardive dyskinesia. Am. J. Psychiatry 147, 505-506.
24. Esterbauer H. and Cheeseman K. H. (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186, 407-421.
25. Goldstein S. R., Matsumoto R. R., Thompson T. L., Patrick R. L., Bowen W. D., and Walker J. M. (1989) Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons. Synapse 4, 254-258.
26. Goodman Y., Bruce A. J., Cheng B., and Mattson M. P. (1996) Estrogen attenuates and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
27. Goossens V., Grooten J., De Vos K., and Fiers W. (1995) Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8115-8119.
28. Greene L. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
29. Griffith O. W. (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
30. Griffith O. W. (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 258, 1591-1598.
31. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
32. Halliwell B. (1987) Oxidants and human disease: some new concepts. FASEB J. 1, 358-364.
33. Halliwell B. and Gutteridge J. M. C. (1993) Free Radicals in Biology and Medicine. Clarendon Press, Oxford.
34. Heller R. and Kronke M. (1994) Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 126, 5-9.
35. Jacobson M. D. (1996) Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21, 83-86.
36. Jacobson M. D. and Raff M. C. (1995) Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374, 814-816.
37. June C. H. and Rabinovitch P. S. (1994) Intracellular ionized calcium. Methods Cell Biol. 41, 149-174.
38. Kane J. M. (1995) Tardive dyskinesia: epidemiological and clinical presentation, in Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 1485-1502. Raven Press, New York.
39. Korpi E. R., Costakos D. T., and Wyatt R. J. (1985) Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomes. Biochem. Pharmacol. 34, 2923-2927.
40. Kruman I., Guo Q., and Mattson M. P. (1998) Calcium and reactive oxygen species mediate staurosporin-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51, 293-308.
41. Lafon-Cazal M., Pietri S., Culcasi M. and Bockaert J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
42. Leist M. and Nicotera P. (1997) The shape of cell death. Biochem. Biophys. Res. Commun. 236, 1-9.
43. Lohr J. B., Cadet J. L., Lohr M. A., Larson L., Wasli E., Wade L., Hylton R., Vidoni C., Jeste D. V., and Wyatt R. J. (1988) Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizopthr. Bull. 14, 291-296.
44. Lohr J. B., Underhill S., Moir S., and Jeste D. V. (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol. Psychiatry 28, 535-539.
45. Macho A., Hirsch T., Marzo I., Marchetti P., Dallaporta B., Susin S. A., Zamzami N., and Kroemer G. (1997) Glutathione depletion is an early and calcium depletion is a late event of thymocyte apoptosis. J. Immunol. 158, 4612-4619.
46. Mackay A. V. P., Iversen L. L., Rossor M., Spokes E., Bird E., Arregui A., Creese I., and Snyder S. H. (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiatry 39, 991-997.
47. Mahadik S. P. and Mukherjee S. (1996) Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res. 19, 1-17.
48. Maher P. and Davis J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 6394-6401.
49. Mehlen P., Kretz-Remy C., Préville X., and Arrigo A.-P. (1996) Human hsp27, Drosophila hsp27 and human αB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFα-induced cell death. EMBO J. 15, 2695-2706.
50. Meister A. (1995) Glutathione metabolism. Methods Enzymol. 251, 3-7.
51. Monyer H., Hartley D. M., and Choi D. W. (1990) 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 5, 121-126.
52. Morimoto B. H. and Koshland D. E. (1990) Induction and expression of long and short term neurosecretory potentiation in a neural cell fine. Neuron 5, 875-880.
53. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L., and Coyle J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547-1558.
54. Pai B. N., Janakiramaiah N., Gangadhar B. N., and Ravindranath V. (1994) Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psyehotics following haloperidol administration. Biol. Psychiatry 36, 489-491.
55. Petit P. X., Susin S.-A., Zamzami N., Mignotte B., and Kroemer G. (1996) Mitochondria and programmed cell death: back to the future. FEBS Lett. 396, 7-13.
56. Reers M., Smith T. W., and Chen L. B. (1991) J-Aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30, 4480-4486.
57. Reers M., Smiley S. T., Mottola-Hartshorn C., Chen A., Lin M., and Chen L. B. (1995) Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 260, 406-417.
58. Reynolds I. J. and Hastings T. G. (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15, 3318-3327.
59. Sagara Y., Dargusch R., Klier F. G., Schubert D., and Behl C. (1996) Increased antioxidant enzyme activity in amyloid β protein resistant cells. J. Neurosci. 16, 497-505.
60. Sagara Y., Dargusch R., Chambers D., Davis J., Schubert D., and Maher P. (1998) Cellular mechanisms of resistance to chronic oxidative stress. Free Radic. Biol. Med. (in press).
61. Scatton B. (1977) Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur. J. Pharmacol. 46, 363-369.
62. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Patrick J., Steinbach J. H., Culp W., and Brandt B. L. (1974) Clonal cell lines from the rat central nervous system. Nature 249, 224-227.
63. Schulze-Oshoff K., Bakker A. C. Vanhaesebroeck B., Beyaert R., Jacob W. A., and Fiers W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondria functions. J. Biol. Chem. 267, 5317-5323.
64. Shivakumar B. R. and Ravindranath V. (1993) Oxidative stress and thiol modification induced by chronic administration of haloperidol. J. Pharmacol. Exp. Ther. 265, 1137-1141.
65. Smiley S. T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T. W., Steele G. D., and Chen L. B. (1991) Intracellular heterogeneity in mitochondrial membrane potential revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 88, 3671-3675.
66. Tan S., Sagara Y., Liu Y., Maher P., and Schubert D. (1998) The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. (in press).
67. Tietze F. (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
68. Troy C. M. and Shelanski M. L. (1994) Down-regulation of copper/ zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc. Natl. Acad. Sci. USA 91, 6384-6387.
69. Ubezio P. and Civoli F. (1994) Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic. Biol. Med. 16, 509-516.
70. Van Putten T., Marder S. R., Wirsching W. C., Aravagiri M., and Chabert N. (1991) Neuroleptic plasma levels. Schizophr. Bull. 17, 197-216.
71. Vilner B. J. and Bowen W. D. (1993) σ Receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture. Eur. J. Pharmacol. 244, 199-201.
72. Vilner B. J., de Costa B. R., and Bowen W. D. (1995) Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability. J. Neurosci. 15, 117-134.
73. Vogt M. and Dulbecco R. (1963) Steps in the neoplastic transformation of hamster embryo cells by polyoma virus. Proc. Natl. Acad. Sci. USA 49, 171-179.
74. 2O release assessed by charcoal adsorption. J. Neurosci. Methods 48, 123-129.
75. Walker J. M. and Hunter W. S. (1994) Role of sigma receptors in motor and limbic system function. (Abstr.) Neuropsychopharmacology 10, 837S.
76. Walker J. M., Matsumoto R. R., Bowen W. D., Gans D. L., Jones K. D., and Walker F. O. (1988) Evidence for a role of haloperidol-sensitive σ-"opiate" receptors in the motor effects of antipsychotic drugs. Neurology 38, 961-965.
77. Wallach D., Boldin M., Varfolomeev E., Beyaert R., Vandenabeele P., and Fiers W. (1997) Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410, 96-106.
78. Wong G. H. W., Elwell J. H., Oberley L. W., and Goeddel D. V. (1989) Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931.
79. Wu Y., Taylor B. M., and Sun F. F. (1996) Alterations in reactive oxygen, pH, and calcium in astrocytoma cells during lethal injury. Am. J. Physiol. 270, C115-C124.
80. Zimmerman R. J., Marafino B. J. Jr., Chan A., Landre P., and Winkelhake J. L. (1989) The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. J. Immunol. 142, 1405-1409.